Gene · 81793
Papers2,018
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,018
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pathomorphological Manifestations and the Course of the Cervical Cancer Disease Determined by Variations in the TLR4 Gene. | Diagnostics (Basel) | 2023 | 37370894 | PubTator, text mining | PubMed |
| The Molecular Basis and Clinical Consequences of Chronic Inflammation in Prostatic Diseases: Prostatitis, Benign Prostatic Hyperplasia, and Prostate Cancer. | Cancers (Basel) | 2023 | 37370720 | PubTator, text mining | PubMed |
| Microenvironment modulation by key regulators of RNA N6-methyladenosine modification in respiratory allergic diseases. | BMC Pulm Med | 2023 | 37328853 | PubTator, text mining | PubMed |
| Toll-like Receptor Response to Human Immunodeficiency Virus Type 1 or Co-Infection with Hepatitis B or C Virus: An Overview. | Int J Mol Sci | 2023 | 37298575 | PubTator, text mining | PubMed |
| Psoriatic Arthritis: Development, Detection and Prevention: A Scoping Review. | J Clin Med | 2023 | 37298045 | PubTator, text mining | PubMed |
| Recent Advances in Studying Toll-like Receptors with the Use of Computational Methods. | J Chem Inf Model | 2023 | 37285179 | PubTator, text mining | PubMed |
| Uncovering new insights into the role of the ubiquitin ligase Smurf1 on the regulation of innate immune signaling and resistance to infection. | Front Immunol | 2023 | 37228615 | PubTator, text mining | PubMed |
| Employing computational tools to design a multi-epitope vaccine targeting human immunodeficiency virus-1 (HIV-1). | BMC Genomics | 2023 | 37226084 | PubTator, text mining | PubMed |
| Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity. | J Immunother Cancer | 2023 | 37208130 | PubTator, text mining | PubMed |
| Menstrual disturbances following COVID-19 vaccination: A probable puzzle about the role of endocrine and immune pathways. | J Reprod Immunol | 2023 | 37201456 | PubTator, text mining | PubMed |
| Large-scale functional screen identifies genetic variants with splicing effects in modern and archaic humans. | Proc Natl Acad Sci U S A | 2023 | 37192163 | PubTator, text mining | PubMed |
| TLRs: Innate Immune Sentries against SARS-CoV-2 Infection. | Int J Mol Sci | 2023 | 37175768 | PubTator, text mining | PubMed |
| Synucleinopathies Take Their Toll: Are TLRs a Way to Go? | Cells | 2023 | 37174631 | PubTator, text mining | PubMed |
| Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: Gene expression and protein profiles. | Front Neurol | 2023 | 37168665 | PubTator, text mining | PubMed |
| Toll-like receptor expression profile of stem/progenitor cells from human exfoliated deciduous teeth. | Int J Paediatr Dent | 2023 | 37158295 | PubTator, text mining | PubMed |
| Higher Serum Vitamin D Levels have a Positive Association with the Incidence of Recidivans Form of Cutaneous Leishmaniasis; A Cross-Sectional Study. | Indian J Dermatol | 2023 | 37151279 | PubTator, text mining | PubMed |
| Identification and characterization of Toll-like receptor 14d in Northeast Chinese lamprey (Lethenteron morii). | Front Immunol | 2023 | 37143659 | PubTator, text mining | PubMed |
| Intersections between innate immune response and gastric cancer development. | World J Gastroenterol | 2023 | 37124883 | PubTator, text mining | PubMed |
| Innate Immune Recognition, Integrated Stress Response, Infection, and Tumorigenesis. | Biology (Basel) | 2023 | 37106700 | PubTator, text mining | PubMed |
| Toll-like receptors in pathogenesis of neurodegenerative diseases and their therapeutic potential. | Immun Inflamm Dis | 2023 | 37102648 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/81793/papers?page=9